Trials / Terminated
TerminatedNCT01667107
A Pharmacokinetic Analysis of Posaconazole in Lung Transplant Recipients (MK-5592-105)
A Pharmacokinetic Analysis of Posaconazole in the Plasma and Alveolar Compartment of Lung Transplant Recipients
- Status
- Terminated
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 26 (actual)
- Sponsor
- Merck Sharp & Dohme LLC · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This single site study will examine plasma and alveolar compartment (AC) levels of posaconazole in cystic fibrosis (CF) and non-cystic fibrosis (non-CF) lung transplant recipients receiving routine post-operative anti-fungal prophylaxis. Invasive fungal infection rates will be assessed following transplantation.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Posaconazole | |
| DRUG | Calogen® |
Timeline
- Start date
- 2013-01-23
- Primary completion
- 2014-01-16
- Completion
- 2014-01-16
- First posted
- 2012-08-17
- Last updated
- 2018-10-09
- Results posted
- 2015-01-05
Source: ClinicalTrials.gov record NCT01667107. Inclusion in this directory is not an endorsement.